Rifadin Iv Injection, Powder, Lyophilized, For Solution
Product Images NDC 0068-0597

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rifadin Iv (NDC 0068-0597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rifadin 01)

Chemical structure diagram of rifampin, the active ingredient in Rifadin IV injection. The diagram shows the molecular arrangement with rings and functional groups characteristic of rifampin.*

FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Packaging label for Rifadin IV 600 mg/vial, an intravenous lyophilized powder injection of rifampin for injection USP. The carton displays the product name, strength, dosage form, and labeler Sanofi-Aventis U.S. LLC. It indicates the contents include one sterile vial and presents storage instructions, barcode, and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.